The Burrell Behavioral Health clinic has officially transitioned to its new identity. Staff members and executives gathered for a ribbon-cutting ceremony to debut the facility, 1795 W. ...
BIRMINGHAM, WEST MIDLANDS - The UK mental health market reached £14.78 billion in 2024 and is projected to grow to £19.12 billion by 2033 — as 5.2 million NHS mental health referrals in a single year push more Birmingham and West Midlands residents toward private therapy. Phinity Therapy's accredite
Vistagen, a late-stage biopharmaceutical company, announced that its clinical development program for fasedienol nasal spray has achieved minimum safety exposure requirements under ICH E1, the…
Learn about the hormonal disorder polyendocrine metabolic ovarian syndrome (PMOS), formerly called polycystic ovary syndrome (PCOS).
Seaport Therapeutics announced positive Phase 1 data for GlyphAgo (SPT-320), a novel oral prodrug of agomelatine for generalized anxiety disorder (GAD), with results showing consistent safety and…
Seaport Therapeutics reported strong clinical progress and financial momentum in its first quarter 2026 results, with multiple advances across its neuropsychiatry pipeline. The company's GlyphAllo…
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced the presentation of ne
Sage Rosenfeld never liked how she felt after drinking alcohol. But like many young people, she felt pressured to drink during high school.
The generalized anxiety disorder market across the 7MM is expected to grow significantly during the forecast period (2026-2036). Key drivers include the increasing prevalence of the disease, advancements in diagnostic tools, heightened patient awareness, growing investments in innovative...
(MedPage Today) -- Deaths of despair -- fatalities from drugs, alcohol, and suicide -- declined by 16% in 2024, according to a report from Trust for America's Health. Georgia's Pathways to Coverage -- a Medicaid expansion program that conditions...
Reality star Teddi Mellencamp reveals the intense anxiety and panic attacks following her doctors' decision to extend the time between cancer monitoring scans from one to three or four months. She discusses the emotional toll of stage IV cancer, the loneliness of her battle, and her life post-divorc
DALLAS — For many patients, anxiety can start long before testing. Their stomach may twist in knots in the days leading up to the appointment, and nervousness can persist even while waiting for results.
Biopharmaceutical company Cingulate has received a Complete Response Letter from the FDA for its New Drug Application (NDA) for CTx-1301 (dexmethylphenidate HCl), a once-daily treatment for…
Real-world analysis of three years of closed claims data from Symphony Health focused on the third year of the study (2023-2024), comprised of more than 261,000 U.S. adults with fibromyalgia
Moments of joy are common whenever hospital facility dogs show up to spend time with patients. These furry caregivers aren’t the typical therapy dogs volunteers bring to hospitals. They are specially-trained, full-time working dogs allowed to enter sensitive areas where...
Bayer announced that 16 abstracts from studies across its oncology portfolio will be presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, taking place in Chicago from…
"I found out the heartbreaking way that a medically confused woman is rarely considered credible," writes Erin Moriarty, an actor on the television show "The Boys."
At the Australian Stuttering Research Centre, researchers and clinicians are changing the lives of adults and children who stutter.
Protagenic Therapeutics, a clinical-stage biopharmaceutical company, has announced two strategic partnerships to advance its lead candidate PT00114, a first-in-class investigational neuropeptide…
Vistagen, a late clinical-stage biopharmaceutical company developing intranasal product candidates for neuropsychiatric disorders, announced the appointment of Angel S. Angelov, MD, MBA, as Chief…
If your smartwatch is making you anxious, you're not alone. This is what research and experts have to say about it.
(NaturalNews) The Link Between Regular Exercise and Mental HealthRegular physical activity is associated with a significantly lower risk of developing anxiety dis...
MELBOURNE, Australia and NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (NASDAQ: IXHL ), a clinical-stage biopharmaceutical company advancing innovative combination therapies for high-impact indications, today announced the official commencement of its DReAMzz clinical study eva
Without proper identification and effective treatment, obsessive compulsive disorder can be deadly.
Tonix Pharmaceuticals announced a poster presentation at ISPOR 2026 on May 17-20 in Philadelphia analyzing fibromyalgia patients in the United States. The retrospective cohort study analyzed U.S.…
"Scanxiety," or scan anxiety, is the nervousness - and in some cases, significant distress - that comes before, during, and after cancer-related imaging exams. Studies of patients with cancer show that more than half (55%) of people experience these feelings.
Alkermes announced positive topline results from the REVITALYZ phase 3 study evaluating LUMRYZ (sodium oxybate) extended-release oral suspension in adults with idiopathic hypersomnia (IH). LUMRYZ…
Collegium Pharmaceutical completed the acquisition of AZSTARYS (serdexmethylphenidate and dexmethylphenidate), a central nervous system stimulant for the treatment of ADHD in people 6 years of age…
Juan Bonilla Lagos is a Plainview father of two with a history of clinical depression. He has been in ICE custody for seven months.
Vistagen announced preliminary positive findings from the open-label extension of its PALISADE-3 Phase 3 study of fasedienol nasal spray for social anxiety disorder treatment. The compound…
Warriors Heart, the only private and accredited U.S. treatment program dedicated exclusively to "warriors," first responders, veterans, and active-duty service...
Researchers have identified a consistent chemical difference in the brains of people with anxiety. Anxiety has become one of the most visible mental health problems in the United States, showing up not only in clinics but also in schools, workplaces, and everyday family life. Although therapy and me
Vistagen has announced that the last patient completed the final visit in the randomized, double-blind, placebo-controlled portion of PALISADE-4, the company's Phase 3 clinical trial evaluating…
From helping you lose weight to reducing your risk of chronic diseases, the benefits of walking have body-wide perks, experts say.
I’m Dr. Russell Gregory, a Board-Certified Family Medicine Physician at the Bradley County Medical Center Rural Health Clinic in Warren. I’m a recent graduate of the UAMS Southwest Family Medicine Residency Program in Texarkana, Arkansas. A couple weeks ago, Dr. Bradley Biggers opened our Community
Delivers Total Revenues of $3.5 Billion, Representing 8% Reported Growth Compared to First Quarter 2025, and U.S. GAAP Net Earnings of $176 Million Total Revenues Were Up 3% Operationally Compared to First Quarter 2025 Adjusted EBITDA was $1.0 Billion Up 10% Operationally Compared to...
Bombshell lawsuits, a European safety bombshell, and a rogue Medicare program converge in the most dangerous moment in American cannabinoid policy history.
We explore the promise and pitfalls of AI therapy — and what users should know about mental health chatbots.
PMDD is not just PMS. It’s a mood disorder — and not enough people are aware it exists.
New Hampshire's Therapeutic Cannabis Program has seen an increase of 14.5% in new patients, bringing the total registry to nearly 17,000, due to changes in state law that allow more people to qualify for medical marijuana use.
Hemab Therapeutics and Seaport Therapeutics are the newest biotech companies to join the public markets, each with an upsized IPO. According to IPO research firm Renaissance Capital, April was the biggest month for biotech IPO proceeds in more than five years. The post Four Biotech IPOs Raise $1.5B
Kratom is “highly addictive even for people who aren’t addicts,” said Dr. Joe Desanto. “It’s an evil drug. I’m scared for the general public.”
A 42-year-old was scheduled for a hysterectomy after decades of chronic pain. Then, a chance encounter led to a life-changing discovery.
Lifestyle modifications, particularly increased physical activity, have a host of benefits. New research suggests they may ease or even reverse symptoms of Parkinson's disease.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Apr 22, 2026--
Explainer-What to know about psychedelic therapies cited by Trump
Propranolol, hailed by Hollywood celebrities, is considered non-addictive but still comes with risks
After dealing with health anxiety caused by tracking my body's metrics on smartwatches, I took matters into my own hands with expert advice.
RAHWAY, N.J. & NUTLEY, N.J.--(BUSINESS WIRE)--Apr 21, 2026--
A 2026 informational overview of Moonbird's tactile breathing coach technology, EEG brain scan research references, real-time HRV biofeedback, pricing structure, ...
New research challenges widely held assumptions about medicinal cannabis, particularly in mental health care. A sweeping new analysis published in The Lancet Psychiatry challenges one of the fastest-growing trends in modern medicine: the use of cannabis-based treatments for mental health. After revi
With about 1 in 6 Americans 12 and older saying they've used cannabis in the past month, more research is needed on its effects. But U.S. law makes real data hard to find. Here's what we know.
Thriveworks reports on managing travel anxiety, emphasizing the importance of recognizing fears, controlling what you can, and preparing coping strategies.
If your smartwatch or smart ring is giving you health anxiety or hypochondria, these are the steps experts recommend you take.
Tonix Pharmaceuticals announced the publication of pharmacokinetic research on TONMYA (cyclobenzaprine HCl sublingual tablets), the first new FDA-approved treatment for fibromyalgia in adults in…
While anxiety itself is a normal, adaptive emotion that helps people respond to perceived threats, it becomes an anxiety disorder when fears or worry are persistent, intense, and start interfering…
Enanta Pharmaceuticals has announced the first participant enrollment in a Phase 1 clinical trial of EDP-978, an oral, once-daily KIT inhibitor being developed to treat chronic urticaria and other…
(NaturalHealth365) Anxiety disorders affect approximately 30% of American adults, making them the most common mental illness in the country. For decades, treatment has centered almost entirely on pharmaceutical intervention. But, a new [...]
This proposal outlines a unified primary care payment model across Medi-Cal, CalPERS, and Covered California. The post Medi-Cal Bold Idea — Multipayer Primary Care Payment Reform Model appeared first on California Health Care Foundation .
Dentistry.com reports that rising dental emergencies are increasing demand for after-hours dentist services, alleviating pressure on crowded ERs and offering more accessible care.
Acadia Pharmaceuticals announced that DAYBUE STIX (trofinetide) for oral solution, a dye- and preservative-free powder formulation of trofinetide, is now broadly available in the United States for…
Woburn, MA, April 06, 2026 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, Inc. announced that ARYNTATM (lisdexamfetamine dimesylate) Oral Solution is now available in the United States for treating ADHD in adults and pediatric patients 6 years and older. Arynta, a ready-to-use...
MALVERN, Pa., April 07, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the–Company–), a medical technology company focused on designing, developing, and ...
Key Facts: SK Life Science, Inc. will present multiple posters at the American Academy of Neurology (AAN) Annual Meeting (April 18–22, 2026, Chicago, Illinois) Cenobamate data includes clinical outcomes, real-world evidence, pharmacokinetics and long-term efficacy New analysis presented...
Auto-brewery syndrome can wreak havoc on people’s lives and reputations. The post The mystifying syndrome that makes people spontaneously drunk appeared first on Boston.com .
Newleos Therapeutics announced that the first participant has been dosed in the company's third Phase 1b study of NTX-1955, designed to evaluate its safety and tolerability in generalized anxiety…
This article reviews the evidence for magnesium, riboflavin, CoQ10, feverfew, vascular tone, and oxidative balance. It also highlights the growing field of nutritional neuroscience and personalized, data-driven approaches to migraine prevention.
Nighttime anxiety was leaving me awake for hours, until I tried this one trick. I asked experts how and why it works.
A new review in The Lancet Psychiatry finds little evidence that marijuana reduces symptoms of anxiety, depression or PTSD while many users self‐medicate.
Cingulate Inc., a biopharmaceutical company developing ADHD treatments using its proprietary Precision Timed Release (PTR) drug delivery platform, reported fourth quarter and full-year 2025…
Seasoned leader brings more than 30 years of medical device experience, with a proven track record of growing revenue, earnings, and cash flow across multiple ...
By Sandee LaMotte, CNN (CNN) — Using medical or recreational marijuana to ease symptoms of numerous mental health conditions doesn’t work, according to two new analyses of existing gold-standard research. Medical marijuana includes products with cannabidiol, or CBD, and delta-9-tetrahydrocannabinol,
BY THE OPTIMIST DAILY EDITORIAL TEAM When anxiety starts creeping in, many people instinctively reach for music. A calming playlist, a pair of headphones, and a few quiet minutes can make a noticeable difference. Science increasingly backs up that instinct, with new research suggesting that the leng
Talk about your fears, normalise difficult emotions, get up and move: experts share their strategies for managing anxiety at different stages of lifeWe are living in an age of anxiety. A 2023 survey by the Mental Health Foundation found that one in five people in the UK experience anxiety all or mos
Imagine you're about to give a presentation to a room full of people.
The Population Health Initiative awarded 13 $25,000 Tier 1 pilot grants in spring quarter 2024 to interdisciplinary University of Washington research teams to investigate pressing population health challenges. The funded projects collectively sought to address grand challenges in areas including cli
The shift can be subtle at first. Your motivated teen who once enjoyed staying late at practice now wants to quit her favorite sport. Grades start slipping. You might notice changes in friendships or that the bedroom door stays closed...
TONMYA (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults, was commercially launched in November 2025 Treatment with TONMYA ...
Phase 3 pivotal program initiation for BPL-003 in treatment-resistant depression remains on track for Q2 2026 following successful End‐of‐Phase 2 meeting with the U.S. Food and Drug AdministrationOn-track for VLS-01 Phase 2 Elumina trial topline data readout anticipated in H2...
Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime is the first new FDA-approved treatment for fibromyalgia in adults in more than 15 years
NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Vistagen Therapeutics, Inc. (“Vistagen” or the “Company”) (NASDAQ: VTGN) investors of an upcoming deadline involving a securities fraud class action lawsuit...
Psychologists are expanding the use of virtual reality in therapeutic settings, developing interventions that help patients develop stronger connections to their future selves and improve…
This Rare Disease Day (February 28, 2026), read on to learn more about five orphan conditions, the people they affect and the UC San Diego Sanford Stem Cell Institute researchers fanning the flames of hope for patients around the globe.
Breakthrough Therapy Designation Based on Positive RECONNECT Phase 2 Clinical Data --
Robert F. Kennedy Jr. has criticized the broadening use of anxiety medications, claiming they’re harmful. Doctors and researchers say the MAHA movement is misrepresenting drugs that have been proved to safely treat chronic anxiety and point to broader social changes to explain their increased use.
Robert F. Kennedy Jr. has criticized the broadening use of anxiety medications, but doctors and researchers say the MAHA movement is misrepresenting drugs that have been proven to help.
NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Vistagen Therapeutics, Inc. (NASDAQ: VTGN). ...
81.8% of patients with bothersome tinnitus treated with Lenire at New York Hearing Doctors reported significant improvement in a real-world clinical setting.1,2 Patients ...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Vistagen To Contact Him Directly To Discuss Their Options
SAN DIEGO, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a class action was filed on behalf of all investors who purchased or otherwise acquired Vistagen Therapeutics, Inc. (NASDAQ: VTGN) common stock between April 1, 2024 and...
Obsession with beating biological clock identified as damaging new addiction
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Feb 12, 2026--
Looking for something specific? Search the full archive.
